Primary hyperparathyroidism is a common endocrine disorder that occurs due to excessive secretion of parathyroid hormone (PTH) by one or more of the four parathyroid glands.

This results in abnormal calcium metabolism, leading to a host of symptoms such as bone pain, osteoporosis, kidney stones, and fatigue. The most effective treatment for primary hyperparathyroidism is surgical removal of the affected parathyroid gland(s), also known as parathyroidectomy.

However, there are several alternative treatments available for those who may not be suitable candidates for surgery or prefer non-surgical options.

Surgical Treatment

Parathyroidectomy is the gold standard treatment for primary hyperparathyroidism, with a success rate of over 95%. The surgical approach may vary depending on the location of the affected gland(s) and the surgeon’s preference.

The two most common types of parathyroidectomy are:.

Minimally invasive parathyroidectomy (MIP)

This approach involves removing only the affected gland(s) through a small incision in the neck, using a minimally invasive technique that reduces the risk of complications and speeds up recovery time.

MIP is suitable for patients with a single adenoma or other identifiable lesion, which accounts for 80-85% of cases of primary hyperparathyroidism.

Bilateral neck exploration (BNE)

This approach involves exploring the entire neck to localize all four parathyroid glands and remove any that are enlarged or abnormal.

BNE is typically used for patients with multiglandular disease or those with negative or inconclusive preoperative imaging studies.

Non-surgical Treatment

For patients who are unable or unwilling to undergo surgery, or who have mild or asymptomatic disease, there are several non-surgical treatment options available. These include:.

Observation and monitoring

Patients with mild or asymptomatic hyperparathyroidism may opt for regular observation and monitoring of their condition, with periodic blood tests and imaging studies to track changes in calcium and PTH levels and assess any potential complications.

Medical therapy

There are several medications available that can help manage the symptoms of hyperparathyroidism and lower calcium levels in the blood. However, these drugs are not curative and do not eliminate the underlying problem.

The most common medications used to treat hyperparathyroidism are:.

Cinacalcet

This drug is a calcimimetic agent that mimics the action of calcium on the parathyroid gland, thereby reducing PTH secretion.

Cinacalcet is effective in lowering calcium and PTH levels in most patients, but it may cause side effects such as nausea, vomiting, and dizziness.

Calcitonin

This drug is a hormone that helps regulate calcium metabolism by inhibiting the activity of osteoclasts, cells that break down bone tissue and release calcium into the blood.

Calcitonin is not as effective as cinacalcet in lowering calcium and PTH levels, but it may help relieve bone pain and prevent bone loss.

Dietary modifications

Patients with hyperparathyroidism are advised to adopt a diet low in calcium, phosphorus, and vitamin D, as these nutrients can exacerbate high blood calcium levels.

This involves limiting intake of dairy products, leafy greens, nuts, and vitamin supplements, and increasing fluids to help flush out excess calcium from the kidneys.

Conclusion

Primary hyperparathyroidism is a common endocrine disorder that can cause a range of symptoms and complications if left untreated.

The most effective treatment for most patients is surgical removal of the affected gland(s), which can improve calcium metabolism and alleviate symptoms. However, for those who are unable or unwilling to undergo surgery, or who have mild or asymptomatic disease, there are several alternative treatment options available that can help manage symptoms and prevent complications.